麻豆传媒

Gastroenterology >

Pancreatic Diseases

News, opinions and meeting coverage in gastroenterology.

Surgery Improves Survival for most pNETs

Mortality odds 70%-80% lower for all but stage I disease

ACG: Focus on the Practical at Annual Meeting

Topics will range from gluten contamination to artificial intelligence for polyp detection

Microbiome Dysbiosis Promotes Pancreatic Disease

Microbiome check may benefit those at risk for pancreatitis and cancer

Pancreatic Ca Gets 20-Month Survival Boost

Aggressive post-surgery chemo regimen touted as new standard of care

Pre-Surgical CRT May Boost Survival in Pancreatic Ca

Further data needed to clarify best approach and who would benefit most

Pancreatitis Raises Risk of Later Cancer

Likelihood of pancreatic cancer increased beyond 5 years after the acute episode

Snus Cleared of Pancreatic Cancer Risk

Pooled data contradict earlier analysis

ESTRO: Survival in Pancreatic Ca Rises with RT Dose

Also: cartoons during RT, brachytherapy for penile cancer

DDW 2017: Diversity Will Be Meeting's Strength

Four-society meeting has plenty to offer across and among specialties

FDA Issues Warning on IBS Drug Viberzi

Must be avoided in patients whose gallbladders have been removed

ECC Roundup: Breast Conservation Benefit Varies by Age

And other reports from the European Cancer Congress

Fraud Rounds: Grant Fakery Earns Practice Ban

Cancer researcher struck from U.K. medical register after fabricating data in grant applications

Victoza Accused of Causing Pancreatitis

The watchdog group Public Citizen has conducted its own analysis of FDA adverse event reports and concluded that the type 2 diabetes drug liraglutide(Victoza) likely causes pancreatitis, the group said.

Combo Active in Neuroendocrine Cancers

SAN FRANCISCO -- More than 90% of patients with neuroendocrine tumors had objective responses or stable disease when treated with an off-the-shelf chemotherapy doublet, results of a small study showed.

FDA Panel Rejects Cystic Fibrosis Drug

SILVER SPRING, Md. -- An FDA advisory committee has voted against approval of liprotamase (Sollpura), a pancreatic enzyme product for cystic fibrosis and other diseases that cause pancreatic insufficiency, saying there is not enough evidence that the drug works better than agents already on the market.

Rare Complication Leaves Gastric Bypass Patients Almost Disabled

ROCHESTER, Minn.-A rare complication of Roux-en-Y gastric bypass surgery is hyperfunction of insulin-producing beta cells, which causes potentially life-threatening neuroglycopenia, say Mayo clinicians.